GGrantIndex
← Leaderboards

Jay Fitzgerald Dorsey

University Of Pennsylvania

$6,888,388
Attributed
$9,468,614
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY201125
$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,468,614 · 5

By mechanism

R01$6,920,971 · 3
R25$1,615,743 · 1
K08$931,900 · 1

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms

Research focus

Malignant NeoplasmsRadiationRadiation TherapyEvaluationImageTumorCharacteristicsBiologicalMethodologyFoundationsLeadRadiation OncologyRadiobiologyMouse ModelNeoplastic CellGliomaInnovationOperative Surgical ProceduresMediatingGeneticAdultMalignant Neoplasm Of BrainMolecular TargetChemotherapy

Grant awards (27)

Summer Undergraduate Program to Educate Radiation Scientists (SUPERS)$260,480
R25 · FY2025 · CA · contact PI
Dissecting the biology and consequence of circulating glioma cells$454,546
R01 · FY2024 · CA · contact PI
Summer Undergraduate Program to Educate Radiation Scientists (SUPERS)$218,885
R25 · FY2024 · CA · contact PI
Dissecting the biology and consequence of circulating glioma cells$468,899
R01 · FY2023 · CA · contact PI
Summer Undergraduate Program to Educate Radiation Scientists (SUPERS)$211,944
R25 · FY2023 · CA · contact PI
Dissecting the biology and consequence of circulating glioma cells$468,899
R01 · FY2022 · CA · contact PI
Summer Undergraduate Program to Educate Radiation Scientists (SUPERS)$267,415
R25 · FY2022 · CA · contact PI
Dissecting the biology and consequence of circulating glioma cells$478,223
R01 · FY2021 · CA · contact PI
Dissecting the biology and consequence of circulating glioma cells$476,996
R01 · FY2020 · CA · contact PI
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy$433,777
R01 · FY2020 · CA
Summer Undergraduate Program to Educate Radiation Scientists (SUPERS)$192,336
R25 · FY2020 · CA · contact PI
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy$420,763
R01 · FY2019 · CA
Summer Undergraduate Program to Educate Radiation Scientists (SUPERS)$235,547
R25 · FY2019 · CA · contact PI
Radiation and Receptor Targeted RadioTheranostic Nanoparticles for Glioblastoma$477,452
R01 · FY2018 · CA · contact PI
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy$433,777
R01 · FY2018 · CA
Summer Undergraduate Program to Educate Radiation Scientists (SUPERS)$229,136
R25 · FY2018 · CA · contact PI
Radiation and Receptor Targeted RadioTheranostic Nanoparticles for Glioblastoma$478,279
R01 · FY2017 · CA · contact PI
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy$433,777
R01 · FY2017 · CA
Radiation and Receptor Targeted RadioTheranostic Nanoparticles for Glioblastoma$479,083
R01 · FY2016 · CA · contact PI
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy$433,777
R01 · FY2016 · CA
Radiation and Receptor Targeted RadioTheranostic Nanoparticles for Glioblastoma$485,893
R01 · FY2015 · CA · contact PI
Targeted Modulation of the Death Receptor as a Therapeutic Strategy for Glioma$189,227
K08 · FY2015 · NS · contact PI
Radiation and Receptor Targeted RadioTheranostic Nanoparticles for Glioblastoma$496,830
R01 · FY2014 · CA · contact PI
Targeted Modulation of the Death Receptor as a Therapeutic Strategy for Glioma$189,227
K08 · FY2014 · NS · contact PI
Targeted Modulation of the Death Receptor as a Therapeutic Strategy for Glioma$189,227
K08 · FY2013 · NS · contact PI
Targeted Modulation of the Death Receptor as a Therapeutic Strategy for Glioma$189,227
K08 · FY2012 · NS · contact PI
Targeted Modulation of the Death Receptor as a Therapeutic Strategy for Glioma$174,992
K08 · FY2011 · NS · contact PI